SRC and cancer: While this family of kinases is not frequently mutated, it is central for the transmission of many oncogenic signals, promoting survival, angiogenesis, proliferation and invasion.112 Activation of SRC itself is observed in half of all cancers, making it an attractive target for cancer therapy.112,113 Numerous SFK inhibitors have been evaluated for the treatment of cancers in clinical trials.